Allosensitization rate of male patients awaiting first kidney grafts after leuko-depleted blood transfusion

Transplantation

Volumn 93, Issue 4, 2012, Pages 418-422

  Balasubramaniam, Gowrie S ^a   Morris, Matthew ^b   Gupta, Arun ^b   Mesa, Irene Rebello ^a   Thuraisingham, Raj ^b   Ashman, Neil ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

Blood transfusion; Relative risk; Sensitization

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1;

ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEPLETION; GRAFT RECIPIENT; HLA TYPING; HOSPITAL ADMISSION; HUMAN; KIDNEY ALLOGRAFT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK ASSESSMENT; SENSITIZATION; SURGICAL RISK; TREATMENT CONTRAINDICATION;

ADULT; ANTIBODIES; BLOOD TRANSFUSION; CROSS-SECTIONAL STUDIES; GRAFT SURVIVAL; HLA ANTIGENS; HUMANS; IMMUNIZATION; KIDNEY TRANSPLANTATION; LEUKOCYTE REDUCTION PROCEDURES; MALE; MIDDLE AGED; PREVALENCE; SURVIVAL RATE; WAITING LISTS;

EID: 84857036308     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182419864     Document Type: Article

References (31)

1. Terasaki PI, Cai J. Human leukocyte antigen antibodies and chronic rejection: From association to causation. Transplantation 2008; 86: 377.
2. Tait BD, Hudson F, Cantwell L, et al. Luminex technology for HLA antibody detection in organ transplantation. Nephrology 2009; 14: 247.
3. Gibney EM, Cagle LR, Freed B, et al. Detection of donor-specific antibodies using HLA-coated microspheres: Another tool for kidney transplant risk stratification. Nephrol Dial Transplant 2006; 21: 2625.
4. Süsal C, Döhler B, Sadeghi M, et al. HLA antibodies and the occurrence of early adverse events in the modern era of transplantation: A collaborative transplant study report. Transplantation 2009; 87: 1367.
5. Süsal C, Opelz G. Kidney graft failure and presensitization against HLA class I and class II antigens. Transplantation 2002; 73: 1269.
6. Wolfe RA, Ashby VB, Milford EL, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999; 341: 1725.
7. Burlingham WJ, Stratta R, Mason B, et al. Risk factors for sensitization by blood transfusions. Comparison of the UW/Madison and UC/San Francisco donor-specific transfusion experience. Transplantation 1989; 47: 140.
8. Hardy S, Lee SH, Terasaki PI. Sensitization 2001. Clin Transpl 2001; 271.
9. Kakaiya R, Triulzi D, Wright D, et al. Prevalence of HLA antibodies in remotely transfused or alloexposed volunteer blood donors. Transfusion 2010; 50: 1328.
10. Triulzi D, Kleinman S, Kakaiya R, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: Implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion 2009; 49: 1825.
11. Salvatierra O Jr, Vincenti F, Amend W, et al. Deliberate donor-specific blood transfusions prior to living related renal transplantation. A new approach. Ann Surg 1980; 192: 543.
12. Opelz G, Graver B, Terasaki PI. Induction of high kidney graft survival rate by multiple transfusion. Lancet 1981; 1: 1223.
13. Marti HP, Henschkowski J, Laux G, et al. Effect of donor-specific transfusions on the outcome of renal allografts in the cyclosporine era. Transpl Int 2006; 19: 19.
14. Bushell A, Karim M, Kingsley CI, et al. Pretransplant blood transfusion without additional immunotherapy generates CD25-CD4+ regulatory T cells: A potential explanation for the blood-transfusion effect. Transplantation 2003; 76: 449.
15. Hiesse C, Busson M, Buisson C, et al. Multicenter trial of one HLA-DRmatched or mismatched blood transfusion prior to cadaveric renal transplantation. Kidney Int 2001; 60: 341.
16. Vella JP, O'Neill D, Atkins N, et al. Sensitization to human leukocyte antigen before and after the introduction of erythropoietin. Nephrol Dial Transplant 1998; 13: 2027.
17. Norfolf DR, Williamson LM. Leucodepletion of blood products by filtration. Blood Rev 1995; 9: 7.
18. Sniecinski I, O'Donnell MR, Nowicki B, et al. Prevention of refractoriness and HLA-alloimmunization using filtered blood products. Blood 1988; 71: 1402.
19. Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunisation and refractoriness to platelet transfusions. N Engl J Med 1997; 337: 1861.
20. Seftel MD, Growe GH, Petraszko T, et al. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness. Blood 2004; 103: 333.
21. Llewelyn CA, Hewitt PE, Knight RSG, et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 2004; 363: 417.
22. Koon MV, Vanprooijen HC, Moes M, et al. Use of leucocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunization-A prospective, randomized trial. Blood 1991; 77: 201.
23. Billing RJ, Safani M, Peterson P. Soluble HLA antigens present in normal human serum. Tissue Antigens 1977; 10: 75.
24. Everett ET, Kao KJ, Scornik JC. Class I HLA molecules on human erythrocytes. Quantitation and transfusion effects. Transplantation 1987; 44: 123.
25. McPherson ME, Anderson AR, Castillejo MI, et al. HLA alloimmunization is associated withRBCantibodies in multiply transfused patients with sickle cell disease. Pediatr Blood Cancer 2010; 54: 552.
26. Pagani FD, Dyke DB, Wright S, et al. Development of anti-major histocompatibility complex class I or II antibodies following left ventricular assist device implantation: Effects on subsequent allograft rejection and survival. J Heart Lung Transplant 2001; 20: 646.
27. Hirata AA, McIntire FC, Terasaki PI, et al. Cross reactions between human transplantation antigens and bacterial lipopolysaccharides. Transplantation 1973; 15: 441.
28. Morales-Buenrostro LE, Terasaki PI, Marino-Vázquez LA, et al. "Natural" human leukocyte antigen antibodies found in nonalloimmunized healthy males. Transplantation 2008; 86: 1111.
29. Karpinski M, Pochinco D, Dembinski I, et al. Leukocyte reduction of red blood cell transfusions does not decrease allosensitization rates in potential kidney transplant candidates. J AmSoc Nephrol 2004; 15: 818.
30. Aalten J, Bemelman FJ, van den Berg-Loonen EM, et al. Pre-kidneytransplant blood transfusions do not improve transplantation outcome: A Dutch national study. Nephrol Dial Transplant 2009; 24: 2559.
31. Guidelines for the Blood Transfusion Services in the UK 2007, UK Blood Transfusion and Tissue Transplantation Services.